Preclinical study data published online in the scientific journal Nutrition & Diabetes reports that tetrahydrocannabivarin (THCV) — a naturally occurring analogue of THC — possesses positive metabolic effects in animal models of obesity. Researchers concluded: “Based on these data, it can be suggested that THCV may be useful for the treatment of the metabolic syndrome and/or type 2 diabetes (adult onset diabetes), either alone or in combination with existing treatments.”
Recent preclinical studies published over the past weeks provide further evidence that cannabinoids are both neuroprotective and cardioprotective.
The consumption of legal hemp seed nutritional oil, in conjunction with the intake of evening primrose oils and a restrictive diet high in Hot-natured foods (such as pepper) and low in saturated fats and sugars, is associated with “significant improvement” in symptom management and immunological characteristics in subjects with multiple sclerosis, according to clinical trial data published this month in the scientific journal BioImpacts.
Adults with a history of marijuana use have a lower prevalence of type 2 diabetes…
The oral administration of the non-psychotropic cannabis plant constituent cannabidiol (CBD) is safe and well…
America’s top drug cop is clearly not an expert in agriculture. So why is Obama’s…
The administration of the non-psychotropic cannabis plant constituent cannabidiol (CBD) is protective in an experimental…
The combined administration of the plant cannabinoids THC and CBD (cannabidiol) provide neuroprotection in rat…